This invention relates to quercetin derivative, its preparation, and a pharmaceutical
combination, as well as their medical uses for the prevention or treatment of diseases
related to 5HT1A receptor or neuron cell damages, including Alzeheimer's
disease, drug or alcohol dependence, sleep disorders or panic state; and for delaying
senility, improving learning and memory, preventing and treatment of neuron cell
damages caused by various kinds of cerebral damages.